Oxurion NV (Germany) Analysis
| TG4 Stock | EUR 0.28 0.00 0.00% |
Oxurion NV is fairly valued with Real Value of 0.27 and Hype Value of 0.28. The main objective of Oxurion NV stock analysis is to determine its intrinsic value, which is an estimate of what Oxurion NV is worth, separate from its market price. There are two main types of Oxurion NV's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Oxurion NV's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Oxurion NV's stock to identify patterns and trends that may indicate its future price movements.
The Oxurion NV stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Oxurion NV's ongoing operational relationships across important fundamental and technical indicators.
Oxurion |
Oxurion Stock Analysis Notes
The company recorded a loss per share of 0.71. Oxurion NV had not issued any dividends in recent years. The entity had 10000:1 split on the 5th of June 2024. Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines that address unmet clinical needs in ophthalmology in Belgium and internationally. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. ThromboGenics operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 78 people. To find out more about Oxurion NV contact Thomas CFA at 32 1 675 13 10 or learn more at https://www.oxurion.com.Oxurion NV Investment Alerts
| Oxurion NV is not yet fully synchronised with the market data | |
| Oxurion NV generated a negative expected return over the last 90 days | |
| Oxurion NV has high historical volatility and very poor performance | |
| Oxurion NV has some characteristics of a very speculative penny stock | |
| Oxurion NV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.13 M. Net Loss for the year was (29.16 M) with profit before overhead, payroll, taxes, and interest of 516 K. | |
| Oxurion NV has accumulated about 85.13 M in cash with (26.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Oxurion Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oxurion NV's market, we take the total number of its shares issued and multiply it by Oxurion NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Oxurion NV Outstanding Bonds
Oxurion NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oxurion NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oxurion bonds can be classified according to their maturity, which is the date when Oxurion NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Oxurion NV Predictive Daily Indicators
Oxurion NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oxurion NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Oxurion Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oxurion NV prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oxurion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oxurion NV. By using and applying Oxurion Stock analysis, traders can create a robust methodology for identifying Oxurion entry and exit points for their positions.
Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines that address unmet clinical needs in ophthalmology in Belgium and internationally. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. ThromboGenics operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 78 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oxurion NV to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Complementary Tools for Oxurion Stock analysis
When running Oxurion NV's price analysis, check to measure Oxurion NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxurion NV is operating at the current time. Most of Oxurion NV's value examination focuses on studying past and present price action to predict the probability of Oxurion NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxurion NV's price. Additionally, you may evaluate how the addition of Oxurion NV to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |